OpenVSafe by OpenVAERS
Search V-safe

YL9-45475-51003

2 vaccinations 1 coded response 13 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
902 / CA
Registered
2021-03-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-13
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-27
    Registered in v-safe
  3. 2021-03-27
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-04-03
    Dose 2 — Pfizer-BioNTech
  5. 2021-04-03
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-17
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-24
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-05-01
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-08
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-15
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-07-03
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-10-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-04-04
    Survey response — 12 months, dose 2
    MedDRA: Cough — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: A cough for three weeks
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-04-04
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  18. 2022-04-06

Vaccinations

DoseDateManufacturerCo-administered
12021-03-13Pfizer-BioNTech
22021-04-03Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-04-04 Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-04-04

Symptoms: A cough for three weeks

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release